Digital Content 
NEWS #PharmaBuzz
03 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250702689193/en/Thermo-Fishers-NGS-Assay-Receives-FDA-Approval-as-a-Companion-Diagnostic-for-ZEGFROVY-and-for-Tumor-Profiling
02 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizals-zegfrovy-sunvozertinib-receives-fda-accelerated-approval-as-the-only-targeted-oral-treatment-for-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-302497351.html
19 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-completes-enrollment-for-its-phase-iii-pivotal-study-of-sunvozertinib-vs-platinum-doublet-in-treatment-naive-nsclc-patients-with-egfr-exon20-insertional-mutations-302486187.html
07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-fda-granted-priority-review-to-dizals-sunvozertinib-new-drug-application-302344065.html
11 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-announces-positive-pooled-data-of-sunvozertinib-in-egfr-tyrosine-kinase-inhibitor-resistant-non-small-cell-lung-cancer-published-in-lung-cancer-302328813.html
08 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dizal-submits-new-drug-application-to-the-us-fda-for-sunvozertinib-in-treating-relapsed-or-refractory-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-302299834.html
Share 